HOSPITAL PROFILE
Zhongshan Hospital in Shanghai: liver cancer, cardiology and named experts
Zhongshan Hospital, Fudan University (复旦大学附属中山医院), is a Shanghai institution with a substantial academic tradition in liver cancer and cardiovascular medicine. Two identifiable figures—Fan Jia and Ge Junbo—help make that expertise concrete for readers researching a specialist second opinion.
Which Zhongshan Hospital is this?
This is Fudan University’s Zhongshan Hospital in Shanghai, not a Guangzhou hospital with a similar English name. Fudan’s affiliated-hospital directory links to its official hospital website and describes its liver-cancer and cardiovascular institutes.
The directory includes older operational statistics, including 2013 activity. We use it for institutional identity and background, not as a source of current patient or staffing totals.
Sources: [1]
Liver cancer: a specialist institute within a broad hospital
The institutional account places liver-cancer expertise alongside cardiovascular, renal and pulmonary medicine. The Liver Cancer Institute and an established liver-surgery research affiliation make this an identifiable area to investigate when looking for a hepatocellular carcinoma specialist.
The advantage for a reader is specificity: liver-cancer expertise can be checked against named clinicians and relevant publications, rather than inferred from a generic description of oncology.
Fan Jia (樊嘉): liver tumour surgery and translational research
A May 2025 Fudan profile describes Fan Jia as a liver-tumour and liver-transplant specialist, a Chinese Academy of Sciences member and Zhongshan’s honorary president. It identifies long-term clinical and translational research work in liver tumours. The title is honorary president; older pages calling him the serving president should not be treated as current.
PubMed records Fan among the authors of a 2024 Cancer Cell review on precision treatment in advanced hepatocellular carcinoma, with a Zhongshan Liver Surgery and Transplantation affiliation. A review synthesizes research; it is not a new randomized trial or evidence that an individual patient will benefit from a particular treatment.
Ge Junbo (葛均波): cardiology with a documented academic role
Fudan’s May 2026 account identifies Ge Junbo as Zhongshan’s cardiology director and a Chinese Academy of Sciences member. It describes him leading the hospital’s cardiology teaching team and discussing developments in coronary intervention and valve procedures.
A July 2026 university report identifies a Zhongshan heart-failure project led by Sun Aijun, with Ge’s guidance and participation, as a recipient of a national science and technology award. The named project shows a wider cardiovascular research programme. It should not be reassigned to Ge as sole project leader or converted into an individual outcome guarantee.
How to use these profiles for an existing diagnosis
For liver cancer, distinguish the question about surgical assessment from one about medical oncology, imaging or pathology. For a cardiovascular review, explain whether the question concerns a documented diagnosis, a proposed intervention or interpretation of existing tests. The appropriate reviewing specialist may differ.
This is why a hospital profile should lead to a clear review question and a relevant department, rather than simply a request for its most famous doctor. Named experts are background examples; their availability must be checked.
What an overseas enquiry needs to establish
China Heal Plus currently focuses on coordinating a written specialist opinion. We check the proposed reviewer, whether the provider can accept the overseas request, required records and the report and language arrangements before confirming the scope and price.
This article does not establish a partnership with Zhongshan or a remote appointment with either named expert. We have not verified a current overseas patient-review route for every department. An international-facing biography alone is not sufficient to confirm one.
Sources and data notes
- Fudan University: affiliated hospitals and Zhongshan identity
Official university directory, including historical 2013 activity; current capacity counts are not reproduced. Checked 7 October 2026.
- Fudan: Fan Jia profile
Published 30 May 2025; identifies honorary president, liver-tumour/transplant expertise and academy membership. Checked 7 October 2026.
- PubMed: precision treatment in advanced hepatocellular carcinoma
Cancer Cell, 2024; indexed as a review. Author Jia Fan and Zhongshan affiliation checked; no individual clinical outcome inferred. Checked 7 October 2026.
- Fudan: Ge Junbo and the Zhongshan cardiology teaching team
Published 16 May 2026; supports current institutional role and academic context. National intervention totals are not attributed to this doctor. Checked 7 October 2026.
- Fudan: Zhongshan heart-failure research award
Published 10 July 2026 about the 8 July award announcement; project led by Sun Aijun, with Ge Junbo guidance and participation. Checked 7 October 2026.
Prepared by China Heal Plus to explain healthcare resources and service choices. This is general information from the linked sources, not an individual medical assessment. Sources are not endorsements of our service.